Welcome to our dedicated page for Cohen & Steers SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating AUM shifts, fee margin details and REIT exposure inside Cohen & Steers’ 300-page disclosures can feel like searching for a needle in a footnote. If you have ever asked, “How do I read the Cohen & Steers annual report 10-K simplified?” or “Where are the Cohen & Steers insider trading Form 4 transactions listed in real time?”, you already know how complex an asset-manager filing can be.
Stock Titan solves that problem. Our AI instantly turns every new Cohen & Steers quarterly earnings report 10-Q filing, 8-K event notice or Cohen & Steers proxy statement executive compensation into plain-English insights. Need to monitor Cohen & Steers Form 4 insider transactions real-time? Want a concise Cohen & Steers earnings report filing analysis that flags AUM growth, fee rate changes and segment performance across liquid real assets? Our platform answers those questions while the document is still hitting EDGAR.
Here is what you can expect the moment CNS files:
- AI-powered summaries that explain complex sections—perfect for understanding Cohen & Steers SEC documents with AI.
- Real-time alerts on executive stock transactions, so you never miss Cohen & Steers executive stock transactions Form 4.
- Line-by-line highlights of 10-K risk factors tied to property cycles, infrastructure regulation and preferred-security credit risk.
- Easy navigation to 8-K items—material fund launches or AUM updates—so Cohen & Steers 8-K material events explained becomes a single click.
Whether you track insider sentiment before allocating capital, compare quarter-over-quarter AUM growth, or dissect fee income trends, our AI lets you move from data to decision faster. Make informed portfolio calls without sifting through hundreds of pages—everything you need from Cohen & Steers SEC filings explained simply is right here.
Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.
Edmond D. Villani, a director of Cohen & Steers, Inc. (CNS), reported multiple equity transactions in early October 2025. On 10/01/2025 he was granted 423 restricted stock units that were 100% vested on the grant date and will be delivered on the third anniversary of the grant. On 10/03/2025 he reported transferring 4,589 shares to the Edmond Dennis Villani Revocable Trust and also a reportable acquisition showing the trust holds 30,259 shares. Following the transactions, Dr. Villani directly owned 5,021 shares and the trust held the stated indirect position. The filings were signed by an attorney-in-fact on 10/03/2025.
Connor Frank T, a director of Cohen & Steers, Inc. (CNS), reported a grant of 423 restricted stock units on 10/01/2025 that were 100% vested on the grant date. The Form 4 shows the RSUs were granted with a $0 price and that the related 423 shares will be delivered to the reporting person on the third anniversary of the grant date. After the reported transaction, the reporting person beneficially owns 23,155 shares of common stock. The filing was signed by an attorney-in-fact on 10/03/2025.
Martin Cohen, a Director and 10% owner of Cohen & Steers, Inc. (CNS), filed a Form 4 reporting changes in his beneficial ownership. The filing shows 8,171,461 shares of common stock held indirectly by the Martin Cohen 2018 Revocable Trust, of which Mr. Cohen disclaims beneficial ownership except to the extent of his pecuniary interest. On 10/01/2025 the filing records a transaction coded A for 423 restricted stock units (RSUs) granted at a $0 price; the RSUs are stated to be 100% vested on the grant date and will be delivered on the third anniversary of the grant date. The Form 4 also reports a disposition of 849,205 shares. The filing is signed by an attorney-in-fact on 10/03/2025.
Cohen & Steers director Dasha Smith was granted 423 restricted stock units (RSUs) on 10/01/2025. The RSUs were 100% vested at grant and will be delivered as 423 shares of common stock to the reporting person on the third anniversary of the grant date. Following the reported transaction, the reporting person is shown as beneficially owning 9,038 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 10/03/2025. The filing discloses no cash price for the grant and lists the ownership as direct.
Karen Wilson Thissen, a director of Cohen & Steers, Inc. (CNS), received an award of 423 restricted stock units on 10/01/2025. The filing shows the RSUs were 100% vested on the grant date and will be delivered in shares to Ms. Thissen Wilson on the third anniversary of the grant. The Form 4 reports an acquisition price of $0 for the award and that the reporting person beneficially owns 1,302 shares of common stock following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
The filing reports that Dolly Lisa, a director of Cohen & Steers, Inc. (CNS), was granted 423 restricted stock units (RSUs) on 10/01/2025. The RSUs were 100% vested on the grant date and are payable in shares on the third anniversary of the grant date, at which time 1,567 shares will be delivered to the reporting person. The reported transaction shows a grant price of $0, and the Form 4 was signed by an attorney-in-fact on 10/03/2025. The report discloses direct beneficial ownership following the transaction as 1,567 shares.
Joseph M. Harvey, Chief Executive Officer and director of Cohen & Steers, Inc. (CNS), reported a Form 4 filing documenting an internal accrual of dividend-equivalent restricted stock units. The filing shows 1,170 shares were acquired on 08/21/2025 as dividend-equivalent restricted stock units that vested (or were credited) at a price of $0. The report also discloses beneficial holdings including 1,287,031 shares reported following the transaction and 305,000 shares held indirectly through an LLC owned by a family trust, of which Mr. Harvey disclaims beneficial ownership except to the extent of his pecuniary interest. The form was signed by an attorney-in-fact on 08/22/2025.
Cohen & Steers insider reported an acquisition of dividend-equivalent restricted stock units. The report shows Elena Dulik, Chief Accounting Officer and SVP, was credited with 38 dividend-equivalent RSUs on 08/21/2025 at no cash cost, increasing her beneficial ownership to 21,213 shares of Common Stock. The filing states these dividend-equivalent units were credited in connection with the company's third-quarter 2025 dividend and were accrued to unvested restricted stock units originally granted in January of 2022, 2023, 2024 and 2025. The Form 4 was signed by an attorney-in-fact on 08/22/2025. The disclosure reflects a routine compensation-related accrual rather than an open-market purchase or sale.
FAQ
What is the current stock price of Cohen & Steers (CNS)?
What is the market cap of Cohen & Steers (CNS)?
